MAR 20, 2022 6:59 AM PDT

Could a Newly Identified Killer T Cell Offer Insight into How We Treat Autoimmune Diseases in the Future?

WRITTEN BY: Alexandria Bass

Scientists have investigated the role of regulatory T cells in autoimmune diseases. Regulatory T cells carry the CD4 protein on their surface and they eliminate immune cells that have gone rogue and attack the body's own tissues. But, as Harvey Cantor, an immunologist at the Dana-Farber Cancer Institute, notes, no treatments using regulatory T cells have yet been approved in the treatment of autoimmune diseases. Perhaps another piece of the puzzle involves the newly identified CD8 T cells that target aberrant autoimmune responses. 

CD8 T cells are known to kill infected and cancerous cells and had previously been shown in mice to quell autoimmune reactions. This latest research published in Science searched for the effect of their human counterpart on autoimmune and infectious diseases.

Although no human cells have the distinct receptor of these CD8 T cells in mice, some human CD8 T cells do have the KIR protein that is similar. Postdoc Jing Li at Stanford University's School of Medicine investigated whether these KIR CD8 T cells could suppress the immune system. 

Researchers in this study found that patients with autoimmune diseases like multiple sclerosis, lupus, and celiac disease had more of these KIR CD8 T cells compared to healthy people. These immune cells also congregated in parts of the body that were targets of the autoimmune process. For example, in patients with celiac disease, more of these cells were found in the small intestine.

Interestingly, the researchers noted, these KIR CD8 T cells were also elevated in people fighting off infections, like COVID-19 and influenza. In the 56 COVID-19 patients examined, those with more severe symptoms had higher levels of KIR-producing cells.

According to immunologist Mark Davis, whose lab at Stanford the research was performed in, these cells may increase in response to a pathogen to kill other T cells that may continue to attack healthy tissues after the pathogen is cleared.

To better understand how these cells work, the investigators examined them in the context of celiac disease. In celiac disease, CD4 T cells promote inflammation when they recognize the gluten protein gliadin. In cell culture studies, Li and his colleagues found that the KIR CD8 T cells killed these CD4 T cells that detected gliadin, seemingly attempting to curb inflammation.

To better understand how protective KIR CD8 T cells are against autoimmunity, the researchers genetically altered mice to have 50% to 75% fewer of these cells. Once exposed to viruses known to trigger autoimmune diseases, these genetically altered mice developed kidney inflammation whereas control mice did not develop any signs of autoimmunity.

Overall, KIR CD8 T cells are said to be rare, making up about 5% of the total pool of CD8 T cells. Their function differs from regulatory T cells in that they kill immune cells that attack healthy tissue whereas regulatory T cells only inhibit these immune cells.

Sources: Science, Science
 

About the Author
BA in Psychology
Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
SEP 15, 2022
Cannabis Sciences
What are cannabis topicals and how do they work?
SEP 15, 2022
What are cannabis topicals and how do they work?
THC and CBD infused lotions, cream, salves and oils are becoming more popular. How do they work and how effective are th ...
SEP 16, 2022
Plants & Animals
CBD for Treating Estrogen Deficiency in Postmenopausal Women
SEP 16, 2022
CBD for Treating Estrogen Deficiency in Postmenopausal Women
Despite many of the stigmas it carries, cannabis and its various compounds have been explored for a variety of health an ...
SEP 26, 2022
Clinical & Molecular DX
The Link Between Diabetes and UTIs is Explained
SEP 26, 2022
The Link Between Diabetes and UTIs is Explained
Diabetes is a chronic disease that causes high levels of blood glucose. This is a result of the pancreas producing insuf ...
SEP 23, 2022
Immunology
Successful Immunotherapy Trial Sends Lupus Into Remission
SEP 23, 2022
Successful Immunotherapy Trial Sends Lupus Into Remission
Immunotherapy is generally known as a treatment for cancer. In CAR T cell therapy, a patient's T cells can be isolat ...
SEP 22, 2022
Cannabis Sciences
Study of Regulations and Risks Associated with Growing Recreational and Medical Cannabis Market
SEP 22, 2022
Study of Regulations and Risks Associated with Growing Recreational and Medical Cannabis Market
A study published in Environmental Health Perspectives advises state and federal regulators to assess the health and saf ...
SEP 30, 2022
Coronavirus
A New Kind of Antiviral Against SARS-CoV-2
SEP 30, 2022
A New Kind of Antiviral Against SARS-CoV-2
Scientists are developing a human version of a drug that was highly beneficial to a hamster model of COVID-19. The drug, ...
Loading Comments...